Try our beta test site
221 studies found for:    "Ewing sarcoma"
Show Display Options
RSS Create an RSS feed from your search for:
"Ewing sarcoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma
Condition: Ewing Sarcoma
Interventions: Biological: allogeneic stem cell transplantation;   Drug: Clyclophosphamide;   Drug: Fludarabina;   Drug: Busulfan;   Drug: Melphalan
2 Recruiting Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Standard treatment (as per protocol ISG SSG III);   Drug: Intensified chemotherapy
3 Recruiting Randomized Phase IIb Trial of Vigil Versus Gemcitabine + Docetaxel for Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Biological: Vigil;   Drug: gemcitabine and docetaxel
4 Active, not recruiting Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults
Condition: Ewing's Sarcoma
Interventions: Drug: Chemotherapy;   Procedure: Surgery;   Radiation: Radiotherapy
5 Recruiting Study in Localized and Disseminated Ewing Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Zoledronic acid;   Drug: Busulfan;   Drug: Treosulfan
6 Terminated Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)
Condition: Ewing's Sarcoma
Intervention: Drug: VCR, CTX, ADM; IFO, VP-16
7 Completed Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma
Condition: Non-Metastatic Ewings Sarcoma
Intervention:
8 Completed Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
Condition: Ewing's Sarcoma
Interventions: Drug: Temozolomide;   Drug: L9-NC
9 Terminated Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
Condition: Ewing's Sarcoma
Interventions: Drug: Vincristine;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Dexrazoxane;   Biological: ImmTher
10 Available Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma
Condition: Ewing Sarcoma
Intervention: Drug: Ganitumab
11 Recruiting Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: Olaparib;   Drug: Temozolomide;   Drug: Irinotecan
12 Withdrawn Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients
Condition: Ewing's Sarcoma
Intervention: Radiation: External Beam Radiotherapy
13 Recruiting Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX
14 Completed Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Drug: Olaparib
15 Recruiting ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated, Incurable Ewing Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: niraparib;   Drug: Temozolomide;   Drug: Irinotecan
16 Active, not recruiting Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma
Conditions: Relapsed Ewing Sarcoma;   Refractory Ewing Sarcoma
Intervention: Drug: Linsitinib
17 Recruiting Protocol for the Treatment of Metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma (ES)
Interventions: Drug: TEMIRI;   Drug: ADM;   Drug: IFO;   Drug: CYC;   Drug: ETO;   Drug: BUMEL;   Drug: VIN
18 Completed
Has Results
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
Condition: Ewing's Sarcoma Family of Tumors
Intervention: Drug: CP-751,871
19 Recruiting Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Condition: Newly Diagnosed Ewing Sarcoma
Interventions: Drug: Cyclophosphamide;   Device: Doxorubicin;   Drug: Vincristine;   Device: Ifosfamide;   Drug: Etoposide;   Procedure: Surgery;   Radiation: Radiation Therapy*;   Drug: Temozolomide;   Drug: Irinotecan
20 Recruiting First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
Condition: Ewing Sarcoma Family of Tumors
Interventions: Drug: VDC-IE x2;   Drug: VDC-IE;   Drug: TEMIRI;   Drug: Consolidation BuMel;   Drug: Maintenance;   Procedure: Local treatment by surgery;   Radiation: Local treatment by radiotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.